CN101843798A - Oral Chinese medicament for treating fracture - Google Patents

Oral Chinese medicament for treating fracture Download PDF

Info

Publication number
CN101843798A
CN101843798A CN200910235870A CN200910235870A CN101843798A CN 101843798 A CN101843798 A CN 101843798A CN 200910235870 A CN200910235870 A CN 200910235870A CN 200910235870 A CN200910235870 A CN 200910235870A CN 101843798 A CN101843798 A CN 101843798A
Authority
CN
China
Prior art keywords
radix
chinese
chinese medicine
chinese medicament
fine powder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN200910235870A
Other languages
Chinese (zh)
Other versions
CN101843798B (en
Inventor
刘新壮
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Liu Xinzhuang
Original Assignee
Lvyuan Qiuzheng Technology Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lvyuan Qiuzheng Technology Development Co Ltd filed Critical Lvyuan Qiuzheng Technology Development Co Ltd
Priority to CN2009102358706A priority Critical patent/CN101843798B/en
Publication of CN101843798A publication Critical patent/CN101843798A/en
Application granted granted Critical
Publication of CN101843798B publication Critical patent/CN101843798B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to an oral Chinese medicament for treating fracture, and belongs to the field of Chinese medicaments for treating osteopathy. The invention aims to provide the Chinese medicament with good effect and quick response. The Chinese medicament is prepared from the following raw materials: drynaria rhizome, Chinese angelica, lucid ganoderma, himalayan teasel root, dragon's blood, radix pseudo-ginseng, radix rehmanniae praeparata and the like. The Chinese medicament has the effects of strengthening body resistance and banking up root, tonifying qi and nourishing blood, activating blood and dissolving stasis, strengthening joining sinew and bones, and joining wound and relieving pain, and has the advantages of obvious effect, exact medicinal effect and quick response.

Description

A kind of Chinese medicine for oral administration for the treatment of fracture
Technical field
The invention belongs to the field of Chinese medicines of treatment osteopathia.
Background technology
After people's fracture, both need synthetism, and needed oral medicine to promote knochenbruch continuous alive again, to avoid osteonecrosis.The present back of being intended to fracture promotes continuous Chinese medicine aspect of living, part comes with some shortcomings: the one, and effect is obvious inadequately, the 2nd, it is slower to take effect, so that large quantities of middle-older patients are owing to can not get effective endo-medicine treatment after the fracture, it is, long not firm that the slow disunion of knochenbruch---knochenbruch is not grown, looked slow, both influenced and walked, osteonecrosis had taken place again easily.Patient and family members thereof are satisfied inadequately to this.
At problem set forth above, the invention provides a kind of Chinese medicine for oral administration for the treatment of fracture, it is obvious inadequately that it can solve in this type of treatment by Chinese herbs in the past effect, the slower problem that takes effect, effective, instant effect, it is remarkable to have effect, drug effect is definite, the advantage of quick result.
Summary of the invention
The present invention is achieved through the following technical solutions:
1, a kind of Chinese medicine for oral administration for the treatment of fracture adopts the raw material of Chinese medicine preparation, and filling a prescription is (by weight):
Rhizoma Drynariae 4-30 part Radix Angelicae Sinensis 4-30 part Ganoderma 2-12 part
Radix Dipsaci 4-30 part Sanguis Draxonis 4-30 part Radix Notoginseng 3-20 part
Radix Rehmanniae Preparata 4-30 part
The Chinese medicine for oral administration of this treatment fracture is made by following method:
(1) by above-mentioned weight ratio, Rhizoma Drynariae, Radix Angelicae Sinensis, Radix Dipsaci, Sanguis Draxonis, Radix Rehmanniae Preparata are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Ganoderma, Radix Notoginseng are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; As required, can be made into Chinese medicine electuary, granule, powder, capsule, watered pill, tablets and other formulations.
The present invention is according to the folk tradition prescription, and the theory according to traditional Chinese medical science the body resistance strengthening and constitution consolidating, blood circulation promoting and blood stasis dispelling develops meticulously.Ganoderma, Radix Rehmanniae Preparata benefiting QI and nourishing blood in the side, tranquilizing by nourishing the heart, the body resistance strengthening and constitution consolidating, enhancing human body immunity power; Radix Angelicae Sinensis, Radix Notoginseng blood-supplementing blood-nourishing, blood circulation promoting and blood stasis dispelling promotes the knochenbruch blood circulation; Be aided with the Radix Dipsaci invigorating the liver and kidney, bone and muscle strengthening, continuous folding is hindered; Rhizoma Drynariae the kidney invigorating bone strengthening continues and hinders pain relieving; The Sanguis Draxonis hemostasis and pain-relieving, blood activating and promoting tissue regeneration.All medicine compatibilities bring out the best in each other, and play the body resistance strengthening and constitution consolidating altogether, benefiting QI and nourishing blood, and blood circulation promoting and blood stasis dispelling, bone and muscle strengthening, continuous merit of hindering pain relieving, effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
The specific embodiment
By following embodiment the present invention is done and to specify:
1, get following prescription (weight is unit by gram):
Rhizoma Drynariae 80 gram Radix Angelicae Sinensis 80 kairine sesames 40 grams
Radix Dipsaci 80 gram Sanguis Draxonis 80 gram Radix Notoginseng 60 grams
Radix Rehmanniae Preparata 80 grams
Weight in accordance with regulations, with conventional water extraction process Rhizoma Drynariae, Radix Angelicae Sinensis, Radix Dipsaci, Sanguis Draxonis, Radix Rehmanniae Preparata are extracted, make extractum fine powder 120 grams, Ganoderma, Radix Notoginseng are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder, make fine particle, the capsule of packing into No. 0 is made 785 of Chinese medicinal capsules, and every capsules includes Chinese medicine fine powder and extract 0.28 gram.
2, get following prescription (weight is unit by gram):
Rhizoma Drynariae 150 gram Radix Angelicae Sinensis 150 kairine sesames 60 grams
Radix Dipsaci 150 gram Sanguis Draxonis 150 gram Radix Notoginseng 90 grams
Radix Rehmanniae Preparata 150 grams
By above-mentioned same method, make 1339 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
3, get following prescription (weight is unit by gram):
Rhizoma Drynariae 300 gram Radix Angelicae Sinensis 250 kairine sesames 120 grams
Radix Dipsaci 300 gram Sanguis Draxonis 250 gram Radix Notoginseng 200 grams
Radix Rehmanniae Preparata 300 grams
By above-mentioned same method, make 2642 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
4, get following prescription (by weight):
3 parts of 7 portions of Ganodermas of 7 parts of Radix Angelicae Sinensis of Rhizoma Drynariae
4 parts of 7 portions of Radix Notoginseng of 7 parts of Sanguis Draxonis of Radix Dipsaci
7 parts of Radix Rehmanniae Preparata
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
5, get following prescription (by weight):
8 parts of 20 portions of Ganodermas of 20 parts of Radix Angelicae Sinensis of Rhizoma Drynariae
16 parts of 20 portions of Radix Notoginseng of 20 parts of Sanguis Draxonis of Radix Dipsaci
20 parts of Radix Rehmanniae Preparata
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
Clinical data:
The present invention is an example after with the synthetism of traditional Chinese medical science fracture, through 6 routine clinical observations.Select to be after the synthetism of tcm diagnosis fracture standard: the patient fractures after the synthetism, bone injury ache, and knochenbruch is difficult continuous, and as above symptom can be made a definite diagnosis.In making a definite diagnosis the object of observation, male's 4 examples, women's 2 examples do not have other serious disease, and the age is 32 years old-76 years old, 60 years old mean age.
Efficacy determination:
1, produce effects: bone injury ache is obviously alleviated, and knochenbruch is looked soon, look firmly, but the wounded's normal activity or leave the bed and walk about 3 months.
2, effective: bone injury ache is alleviated to some extent, the knochenbruch basic long healing of going up in 3 months.
3, invalid: knochenbruch pain does not subtract, healing or disunion late after 4 months.
During clinical experiment, withdraw other medicines and health nutrient.Taking Chinese medicinal capsule of the present invention, observed 5 months, is a course of treatment.Instructions of taking: every day 2 times, each 5 capsules, every capsules include Chinese medicine fine powder and extract 0.28 gram, warm water delivery service after meal, symptom promptly has alleviation after 1 month, take 5 months after, symptom is obviously improved.6 philtrums of clinical experiment, produce effects 3 people, effective 3 people, total effective rate 100%.

Claims (1)

1. a Chinese medicine for oral administration for the treatment of fracture adopts the raw material of Chinese medicine preparation, and filling a prescription is (by weight):
Rhizoma Drynariae 4-30 part Radix Angelicae Sinensis 4-30 part Ganoderma 2-12 part
Radix Dipsaci 4-30 part Sanguis Draxonis 4-30 part Radix Notoginseng 3-20 part
Radix Rehmanniae Preparata 4-30 part
The Chinese medicine for oral administration of this treatment fracture is made by following method:
(1) by above-mentioned weight ratio, Rhizoma Drynariae, Radix Angelicae Sinensis, Radix Dipsaci, Sanguis Draxonis, Radix Rehmanniae Preparata are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Ganoderma, Radix Notoginseng are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; As required, can be made into Chinese medicine electuary, granule, powder, capsule, watered pill, tablets and other formulations.
CN2009102358706A 2009-10-28 2009-10-28 Oral Chinese medicament for treating fracture Active CN101843798B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2009102358706A CN101843798B (en) 2009-10-28 2009-10-28 Oral Chinese medicament for treating fracture

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2009102358706A CN101843798B (en) 2009-10-28 2009-10-28 Oral Chinese medicament for treating fracture

Publications (2)

Publication Number Publication Date
CN101843798A true CN101843798A (en) 2010-09-29
CN101843798B CN101843798B (en) 2011-07-27

Family

ID=42768736

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2009102358706A Active CN101843798B (en) 2009-10-28 2009-10-28 Oral Chinese medicament for treating fracture

Country Status (1)

Country Link
CN (1) CN101843798B (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1157198C (en) * 1999-09-10 2004-07-14 蔡振平 Bolus for bone setting and activating collaterals
CN101199707B (en) * 2007-12-29 2010-06-23 冯培森 Bone-knitting plaster for treating fracture and preparing method thereof

Also Published As

Publication number Publication date
CN101843798B (en) 2011-07-27

Similar Documents

Publication Publication Date Title
CN101843690B (en) Chinese medicament for treating osteoporosis
CN101862398B (en) Chinese medicament for treating osteoporosis
CN101843712B (en) Chinese medicament for treating angina
CN101843660B (en) Chinese medicament for treating tachycardia
CN101843759B (en) Oral Chinese medicament for treating fracture
CN101843739B (en) Oral Chinese medicament for treating fracture
CN101843798B (en) Oral Chinese medicament for treating fracture
CN101843741B (en) Chinese medicament for treating femoral head necrosis
CN101843705B (en) Chinese medicament for treating lupus erythematosus
CN101843731B (en) Chinese medicament for treating femoral head necrosis
CN101843799B (en) Oral Chinese medicament for treating fracture
CN101843718B (en) Chinese medicament for treating lupus erythematosus
CN101843753B (en) Chinese medicament for treating angina
CN101850055B (en) Chinese medicament for treating coronary heart diseases
CN101843776A (en) Oral Chinese medicament for treating fracture
CN101843755A (en) Chinese medicament for treating diabetic cardiopathy
CN101843691B (en) Chinese medicament for treating femoral head necrosis
CN101843793B (en) Chinese medicament for treating tachycardia
CN101843720B (en) Chinese medicament for treating angina
CN101850034B (en) Chinese medicament for treating angina
CN101843645B (en) Chinese medicament for treating tachycardia
CN101843758B (en) Chinese medicament for treating coronary disease
CN101843749A (en) Chinese medicament for treating femoral head necrosis
CN101843866A (en) Chinese medicament for treating diabetic feet
CN101879246A (en) Traditional Chinese medicine for treating lupus erythematosus

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: MAIDIHAI PHARMACEUTICAL CO., LTD., BEIJING

Free format text: FORMER OWNER: BEIJING LVYUANQIUZHENG TECHNOLOGY DEVELOPMENT CO., LTD.

Effective date: 20150601

C41 Transfer of patent application or patent right or utility model
COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 100040 SHIJINGSHAN, BEIJING TO: 100162 DAXING, BEIJING

TR01 Transfer of patent right

Effective date of registration: 20150601

Address after: 100162, No. 5 police road, Jinxing Town, Daxing District, Beijing, Xihongmen

Patentee after: Maidihai Pharmaceutical Co., Ltd., Beijing

Address before: 100040 Beijing city Shijingshan District street Babaoshan Lugu Village District No. 7 building 10-602 room

Patentee before: Beijing Lvyuanqiuzheng Technology Development Co., Ltd.

C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20151119

Address after: 100040 Beijing city Shijingshan District double Jinyuan District 16 Building 2 unit 1102

Patentee after: Liu Xinzhuang

Address before: 100162, No. 5 police road, Jinxing Town, Daxing District, Beijing, Xihongmen

Patentee before: Maidihai Pharmaceutical Co., Ltd., Beijing